Chemoinformaics analysis of 2,5-Dihydrofuran
Molecular Weight | 70.091 | nRot | 0 |
Heavy Atom Molecular Weight | 64.043 | nRig | 5 |
Exact Molecular Weight | 70.0419 | nRing | 1 |
Solubility: LogS | 0.796 | nHRing | 1 |
Solubility: LogP | 0.426 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 11 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 11.4828 |
nHD | 0 | BPOL | 7.75524 |
QED | 0.379 |
Synth | 3.709 |
Natural Product Likeliness | 0.923 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.021 |
HIA | 0.002 |
CACO-2 | -4.193 |
MDCK | 0.000042 |
BBB | 0.965 |
PPB | 0.170619 |
VDSS | 0.793 |
FU | 0.771481 |
CYP1A2-inh | 0.257 |
CYP1A2-sub | 0.75 |
CYP2c19-inh | 0.047 |
CYP2c19-sub | 0.694 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.253 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.532 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.194 |
CL | 5.157 |
T12 | 0.793 |
hERG | 0.02 |
Ames | 0.108 |
ROA | 0.45 |
SkinSen | 0.922 |
Carcinogencity | 0.429 |
EI | 0.996 |
Respiratory | 0.149 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.960361 |